[1]
“Nitrosamine Impurities in Pharmaceutical Products: A Comprehensive Review of Sources, Analytical Detection Methods, Toxicological Risks, and Regulatory Guidelines: Nitrosamine Impurities in Pharmaceuticals: Sources, Detection, Risks, and Regulations”, JDDB, vol. 2, no. 3, pp. 23–42, Jul. 2025, doi: 10.61920/3x6f8b82.